Galectin-3-mediated xenoactivation of human monocytes

Transplantation

Volumn 87, Issue 1, 2009, Pages 44-51

  Greenwald, Allen G ^a   Jin, Rongyu ^a   Waddell, Thomas K ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Activation; Endothelial Cells; Galectin 3; Monocytes; Xenotransplantation

Indexed keywords

DIHYDRORHODAMINE 123; GALACTOSYLGALACTOSE; GALECTIN 3; PROTEIN ZO1; SIALIC ACID; HETEROPHILE ANTIGEN; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MONOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; WESTERN BLOTTING; CELL CULTURE; COCULTURE; ENDOTHELIUM; EXTRACELLULAR SPACE; IMMUNOLOGY; METABOLISM; SECRETION; SOLUBILITY;

ANTIGENS, HETEROPHILE; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; ENDOTHELIUM; EXTRACELLULAR SPACE; GALECTIN 3; HUMANS; MONOCYTES; REACTIVE OXYGEN SPECIES; SOLUBILITY;

EID: 58949100716     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318191e6b4     Document Type: Article

References (38)

1. Watts A, Foley A, Awwad M, et al. Plasma perfusion by apheresis through a Gal immunoaffinity column successfully depletes anti-Gal antibody: Experience with 320 aphereses in baboons. Xenotransplantation 2000; 7: 181.
2. Schuurman HJ, Cheng J, Lam T. Pathology of xenograft rejection: A commentary. Xenotransplantation 2003; 10: 293.
3. Manez R, Crespo F, Gonzalez E, et al. Neutralization of anti-alphaGalactosyl antibodies without immunosuppression prevents hyperacute rejection but not acute vascular rejection of pig organs transplanted into baboons. Transplant Proc 2000; 32: 888.
4. Ghanekar A, Luo Y, Yang H, et al. The alpha-Gal analog GAS914 ameliorates delayed rejection of hDAF transgenic pig-to-baboon renal xenografts. Transplant Proc 2001; 33: 3853.
5. Teranishi K, Gollackner B, Buhler L, et al. Depletion of anti-gal antibodies in baboons by intravenous therapy with bovine serum albumin conjugated to gal oligosaccharides. Transplantation 2002; 73: 129.
6. Heckl-Ostreicher B, Wosnik A, Kirschfink M. Protection of porcine endothelial cells from complement-mediated cytotoxicity by the human complement regulators CD59, C1 inhibitor, and soluble complement receptor type 1 Analysis in a pig-to-human in vitro model relevant to hyperacute xenograft rejection. Transplantation 1996; 62: 1693.
7. Fryer JP, Leventhal JR, Pao W, et al. Synthetic peptides which inhibit the interaction between C1q and immunoglobulin and prolong xenograft survival. Transplantation 2000; 70: 828.
8. Rollins SA, Matis LA, Springhorn JP, et al. Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs. Transplantation 1995; 60: 1284.
9. Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964.
10. Diamond LE, McCurry KR, Martin MJ, et al. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation 1996; 61: 1241.
11. Diamond LE, Quinn CM, Martin MJ, et al. A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation 2001; 71: 132.
12. LaVecchio JA, Dunne AD, Edge AS. Enzymatic removal of alpha-galactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies. Transplantation 1995; 60: 841.
13. Ogawa H, Kobayashi T, Yokoyama I, et al. Reduction of alpha-galactosyl xenoantigen by expression of endo-beta-galactosidase C in pig endothelial cells. Xenotransplantation 2002; 9: 290.
14. Sandrin MS, Fodor WL, Mouhtouris E, et al. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1995; 1: 1261.
15. Cohney S, McKenzie IF, Patton K, et al. Down-regulation of Gal alpha(1,3)Gal expression by alpha1,2-fucosyltransferase: Further characterization of alpha1,2-fucosyltransferase transgenic mice. Transplantation 1997; 64: 495.
16. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299: 411.
17. Kolber-Simonds D, Lai L, Watt SR, et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci USA 2004; 101: 7335.
18. Robson SC, Schulte am EJ, Bach FH. Factors in xenograft rejection. Ann N Y Acad Sci 1999; 875: 261.
19. Candinas D, Lesnikoski BA, Robson, SC, et al. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival. Transplantation 1996; 62: 336.
20. Itescu S, Kwiatkowski P, Artrip JH, et al. Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period. Hum Immunol 1998; 59: 275.
21. Xia G, Ji P, Rutgeerts O, et al. Natural killer cell- and macrophage-mediated discordant guinea pig→rat xenograft rejection in the absence of complement, xenoantibody and T cell immunity. Transplantation 2000; 70: 86.
22. Millan MT, Geczy C, Stuhlmeier KM, et al. Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expression. Transplantation 1997; 63: 421.
23. Fox A, Mountford J, Braakhuis A, et al. Innate and adaptive immune responses to nonvascular xenografts: Evidence that macrophages are direct effectors of xenograft rejection. J Immunol 2001; 166: 2133.
24. Hancock WW, Miyatake T, KoyamadaN, et al. Effects of leflunomide and deoxyspergualin in the guinea pig→rat cardiac model of delayed xenograft rejection: Suppression of B cell and C-C chemokine responses but not induction of macrophage lectin. Transplantation 1997; 64: 696.
25. Kwiatkowski P, Artrip JH, Michler RE, et al. Human monocytes bind to ligands on porcine endothelium containing the gal alpha (1,3)-Gal antigen. Transplant Proc 2000; 32: 931.
26. Peterson MD, Jin R, Hyduk S, et al. Monocyte adhesion to xenogeneic endothelium during laminar flowis dependent on alpha-Gal-mediated monocyte activation. J Immunol 2005; 174: 8072.
27. Jin R, Greenwald A, Peterson MD, et al. Human Monocytes recognize porcine endothelium via the interaction of galectin 3 and {alpha}-GAL. J Immunol 2006; 177: 1289.
28. Barondes SH, Castronovo V, Cooper DN, et al. Galectins: A family of animal beta-galactoside-binding lectins. Cell 1994; 76: 597.
29. Hughes RC. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1999; 1473: 172.
30. Hsu DK, Liu FT. Regulation of cellular homeostasis by galectins. Glycoconj J 2004; 19: 507.
31. Liu FT. Regulatory roles of galectins in the immune response. Int Arch Allergy Immunol 2005; 136: 385.
32. Sato S, Hughes RC. Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages. J Biol Chem 1994; 269: 4424.
33. HirabayashiJ, Hashidate T,ArataY, et al. Oligosaccharide specificity of galectins:Asearch byfrontal affinity chromatography. Biochim Biophys Acta 2002; 1572: 232.
34. Kwiatkowski P, Artrip JH, Edwards NM, et al. High-level porcine endothelial cell expression of alpha(1,2)-fucosyltransferase reduces human monocyte adhesion and activation. Transplantation 1999; 67: 219.
35. Dong S, Hughes RC. Macrophage surface glycoproteins binding to galectin-3 (Mac-2-antigen). Glycoconj J 1997; 14: 267.
36. Hughes RC. Galectins as modulators of cell adhesion. Biochimie 2001; 83: 667.
37. Lorenzon P, Vecile E, Nardon E, et al. Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors. J Cell Biol 1998; 142: 1381.
38. Sano H, Hsu DK, Yu L, et al. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. Immunol 2000; 165: 2156.